Suppr超能文献

载脂蛋白B mRNA编辑酶催化多肽样3A胞苷脱氨酶对细小病毒的脱氨酶非依赖性抑制作用

Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.

作者信息

Narvaiza Iñigo, Linfesty Daniel C, Greener Benjamin N, Hakata Yoshiyuki, Pintel David J, Logue Eric, Landau Nathaniel R, Weitzman Matthew D

机构信息

Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California, USA.

出版信息

PLoS Pathog. 2009 May;5(5):e1000439. doi: 10.1371/journal.ppat.1000439. Epub 2009 May 22.

Abstract

The APOBEC3 proteins form a multigene family of cytidine deaminases with inhibitory activity against viruses and retrotransposons. In contrast to APOBEC3G (A3G), APOBEC3A (A3A) has no effect on lentiviruses but dramatically inhibits replication of the parvovirus adeno-associated virus (AAV). To study the contribution of deaminase activity to the antiviral activity of A3A, we performed a comprehensive mutational analysis of A3A. By mutation of non-conserved residues, we found that regions outside of the catalytic active site contribute to both deaminase and antiviral activities. Using A3A point mutants and A3A/A3G chimeras, we show that deaminase activity is not required for inhibition of recombinant AAV production. We also found that deaminase-deficient A3A mutants block replication of both wild-type AAV and the autonomous parvovirus minute virus of mice (MVM). In addition, we identify specific residues of A3A that confer activity against AAV when substituted into A3G. In summary, our results demonstrate that deaminase activity is not necessary for the antiviral activity of A3A against parvoviruses.

摘要

载脂蛋白B mRNA编辑酶催化多肽样蛋白3(APOBEC3)蛋白形成一个胞苷脱氨酶多基因家族,对病毒和逆转录转座子具有抑制活性。与载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G,A3G)不同,载脂蛋白B mRNA编辑酶催化多肽样蛋白3A(APOBEC3A,A3A)对慢病毒没有影响,但能显著抑制细小病毒腺相关病毒(AAV)的复制。为了研究脱氨酶活性对A3A抗病毒活性的贡献,我们对A3A进行了全面的突变分析。通过非保守残基的突变,我们发现催化活性位点以外的区域对脱氨酶和抗病毒活性都有贡献。使用A3A点突变体和A3A/A3G嵌合体,我们表明抑制重组AAV产生不需要脱氨酶活性。我们还发现脱氨酶缺陷的A3A突变体可阻断野生型AAV和小鼠自主细小病毒微小病毒(MVM)的复制。此外,我们确定了A3A的特定残基,当将其替换到A3G中时可赋予对AAV的活性。总之,我们的结果表明脱氨酶活性对于A3A抗细小病毒的抗病毒活性不是必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a6e/2678267/91145c50011f/ppat.1000439.g001.jpg

相似文献

1
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
PLoS Pathog. 2009 May;5(5):e1000439. doi: 10.1371/journal.ppat.1000439. Epub 2009 May 22.
4
Functional domain organization of human APOBEC3G.
Virology. 2008 Sep 15;379(1):118-24. doi: 10.1016/j.virol.2008.06.013. Epub 2008 Jul 18.
5
A DNA sequence recognition loop on APOBEC3A controls substrate specificity.
PLoS One. 2014 May 14;9(5):e97062. doi: 10.1371/journal.pone.0097062. eCollection 2014.
6
Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
Retrovirology. 2007 Aug 29;4:61. doi: 10.1186/1742-4690-4-61.
7
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.
Curr Biol. 2006 Mar 7;16(5):480-5. doi: 10.1016/j.cub.2006.01.031.
8
Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.
J Biol Chem. 2006 Dec 1;281(48):36624-31. doi: 10.1074/jbc.M604980200. Epub 2006 Oct 4.
9
Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.
PLoS One. 2009;4(1):e4277. doi: 10.1371/journal.pone.0004277. Epub 2009 Jan 26.
10
Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.
PLoS One. 2012;7(1):e30036. doi: 10.1371/journal.pone.0030036. Epub 2012 Jan 17.

引用本文的文献

1
APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.
Int J Mol Sci. 2025 Feb 12;26(4):1561. doi: 10.3390/ijms26041561.
2
Regulation of viral replication by host restriction factors.
Front Immunol. 2025 Jan 23;16:1484119. doi: 10.3389/fimmu.2025.1484119. eCollection 2025.
3
An overview of the functions and mechanisms of APOBEC3A in tumorigenesis.
Acta Pharm Sin B. 2024 Nov;14(11):4637-4648. doi: 10.1016/j.apsb.2024.08.020. Epub 2024 Aug 27.
4
Potential Role of APOBEC3 Family Proteins in SARS-CoV-2 Replication.
Viruses. 2024 Jul 16;16(7):1141. doi: 10.3390/v16071141.
5
The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses.
Pathogens. 2024 Feb 20;13(3):187. doi: 10.3390/pathogens13030187.
8
The coevolution between APOBEC3 and retrotransposons in primates.
Mob DNA. 2022 Nov 29;13(1):27. doi: 10.1186/s13100-022-00283-1.
9
APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?
Annu Rev Virol. 2022 Sep 29;9(1):375-395. doi: 10.1146/annurev-virology-092920-030354. Epub 2022 Jun 7.
10
Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
Cell Rep. 2022 Mar 22;38(12):110555. doi: 10.1016/j.celrep.2022.110555.

本文引用的文献

1
Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.
Virology. 2009 May 10;387(2):313-21. doi: 10.1016/j.virol.2009.02.026. Epub 2009 Mar 21.
2
Protein structure homology modeling using SWISS-MODEL workspace.
Nat Protoc. 2009;4(1):1-13. doi: 10.1038/nprot.2008.197.
3
Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Nature. 2008 Nov 6;456(7218):121-4. doi: 10.1038/nature07357. Epub 2008 Oct 12.
4
The AID/APOBEC family of nucleic acid mutators.
Genome Biol. 2008;9(6):229. doi: 10.1186/gb-2008-9-6-229. Epub 2008 Jun 17.
5
HIV-1 Vif, APOBEC, and intrinsic immunity.
Retrovirology. 2008 Jun 24;5:51. doi: 10.1186/1742-4690-5-51.
6
Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
Virology. 2008 Jul 20;377(1):71-9. doi: 10.1016/j.virol.2008.04.012. Epub 2008 May 21.
8
Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.
Nature. 2008 Mar 6;452(7183):116-9. doi: 10.1038/nature06638. Epub 2008 Feb 20.
9
APOBEC3 proteins and reverse transcription.
Virus Res. 2008 Jun;134(1-2):74-85. doi: 10.1016/j.virusres.2007.12.022. Epub 2008 Feb 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验